SPEVIGO
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0597-7705 -
Package NDC
0597-7705-41 -
Package NDC
0597-7705-72 -
Application number
BLA761244 -
SPL ID
021b29b5-64ea-411e-91a8-c1f5015c3d9c -
SPL set ID
41a481ee-3062-45d1-aed5-17e8b105634d -
UNII
5IB2J79MCX -
RxCUI
2610422 -
RxCUI
2610428 -
RxCUI
2678979 -
RxCUI
2678984 -
RxCUI
2716696 -
RxCUI
2716697
What the source publishes
- Labeler
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Active ingredients
- spesolimab-sbzo
- Form
- INJECTION
- Routes
- INTRAVENOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "SPEVIGO",
"splId": "021b29b5-64ea-411e-91a8-c1f5015c3d9c",
"labels": [
{
"setId": "41a481ee-3062-45d1-aed5-17e8b105634d",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=41a481ee-3062-45d1-aed5-17e8b105634d",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=41a481ee-3062-45d1-aed5-17e8b105634d"
}
],
"routes": [
"INTRAVENOUS"
],
"labeler": "Boehringer Ingelheim Pharmaceuticals, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 SYRINGE in 1 CARTON (0597-7705-41) / 300 INJECTION in 1 SYRINGE (0597-7705-38)",
"package_ndc": "0597-7705-41",
"identifierStatus": "well-formed",
"marketing_end_date": "20270430",
"marketing_start_date": "20250528"
},
{
"sample": false,
"description": "2 SYRINGE in 1 CARTON (0597-7705-72) / 300 INJECTION in 1 SYRINGE (0597-7705-38)",
"package_ndc": "0597-7705-72",
"identifierStatus": "well-formed",
"marketing_end_date": "20270430",
"marketing_start_date": "20250528"
}
],
"productId": "0597-7705_021b29b5-64ea-411e-91a8-c1f5015c3d9c",
"useDomain": "unknown",
"dosageForm": "INJECTION",
"productNdc": "0597-7705",
"deaSchedule": null,
"genericName": "spesolimab-sbzo",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": "20270430",
"activeIngredients": [
{
"name": "SPESOLIMAB",
"strength": "300 mg/1"
}
],
"applicationNumber": "BLA761244",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20250528",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000194039",
"N0000194040"
],
"upc": [
"0305970035107"
],
"unii": [
"5IB2J79MCX"
],
"rxcui": [
"2610422",
"2610428",
"2678979",
"2678984",
"2716696",
"2716697"
],
"spl_set_id": [
"41a481ee-3062-45d1-aed5-17e8b105634d"
],
"pharm_class_epc": [
"Interleukin-36 Receptor Antagonist [EPC]"
],
"pharm_class_moa": [
"Interleukin-36 Receptor Antagonists [MoA]"
],
"manufacturer_name": [
"Boehringer Ingelheim Pharmaceuticals, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": null
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0597-7705_021b29b5-64ea-411e-91a8-c1f5015c3d9c"